Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Selbyville, Delaware, July 07, 2022 (GLOBE NEWSWIRE) -- U.S. compounding pharmacies market value is set to reach USD 8.7 billion by 2030, according to a new research report by Global Market...
-
Portland, OR, June 22, 2022 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Cataract Surgery Devices Market was pegged at $8.33 billion in 2020, and is...
-
New York, USA, Jan. 24, 2022 (GLOBE NEWSWIRE) -- A new report on the global medical device manufacturing outsourcing market has been added by Research Dive to its repository. According to the...
-
Jersey City, New Jersey, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Optical Lens Market” By Type (Converging Lenses and Diverging Lenses), By...
-
Pune, India, Feb. 16, 2021 (GLOBE NEWSWIRE) -- The global compounding pharmacies market size is anticipated to register substantial growth rate during the forecast period owing to growing...
-
MUNICH, Germany, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ViGeneron GmbH, a gene therapy company, today announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV)...
-
Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye disease, plus option for additional targetThe companies will use ViGeneron’s proprietary vgAAV...
-
Newark, NJ, Sept. 29, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global compounding pharmacies market is expected to grow from USD 10.44 billion in 2019 and to reach...
-
Northvale, NJ, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced that RetinalGeniX Technologies, Inc. (“RTI”), has entered into an engineering...
-
ATLANTA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today...